AlphaFold predicted structure
GMPPA · Q96IJ6

Mean pLDDT
93.1/ 100
Very high
420 residues
Confidence breakdown
- Very high(≥ 90)82%
- Confident(70–90)12%
- Low(50–70)5%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
GDP-mannose pyrophosphorylase A
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFamilial dysautonomia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalTriple A syndrome
hereditary disease
triple-A syndrome
Intellectual disability - alacrima - achalasia
chromosomal instability with tissue-specific radiosensitivity
smoking initiation
amyotrophic lateral sclerosis
Congenital myasthenic syndromes
congenital myasthenic syndromes with glycosylation defect
genetic developmental and epileptic encephalopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mannose-1-phosphate guanylyltransferase regulatory subunit alpha
Regulatory subunit of the GMPPA-GMPPB mannose-1-phosphate guanylyltransferase complex; reduces the catalytic activity of GMPPB when part of the complex (PubMed:24035193, PubMed:33986552). Mediates allosteric feedback inhibition of GMPPB catalytic activity upon binding GDP-alpha-D-mannose (PubMed:24035193, PubMed:33986552). Together with GMPPB regulates GDP-alpha-D-mannose levels (PubMed:33986552)
GMPPA · Q96IJ6

Mean pLDDT
93.1/ 100
Very high
420 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0